EMFAT
ACER

Emerald Mutual Fund Advisers Trust’s Acer Therapeutics Inc ACER Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-125,000
Closed -$3.04M – 220
2019
Q1 		$3.04M Hold
125,000
– – 0.12% 173
2018
Q4 		$2.52M Hold
125,000
– – 0.12% 172
2018
Q3 		$3.85M Buy
+125,000
New +$3.35M 0.13% 184

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ACER Position: Q2 2019 in Review

Emerald Mutual Fund Advisers Trust sold out of Acer Therapeutics Inc (ACER) in Q2 2019, closing a stake of 125,000 shares — an estimated $3.04M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ACER in Q3 2018 and held it in 3 quarters. The position peaked at $3.85M in Q3 2018. 37 funds tracked by Wall St. Rank hold ACER as of Q2 2019.

  • Emerald Mutual Fund Advisers Trust reported no remaining Acer Therapeutics Inc position as of Q2 2019 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 125,000 Acer Therapeutics Inc shares in Q2 2019, an estimated $3.04M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Acer Therapeutics Inc in Q3 2018 and held it in 3 quarters.
  • Emerald Mutual Fund Advisers Trust's Acer Therapeutics Inc position peaked at $3.85M in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2019.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2019, filed 31 Jul 2019.